G. Stelman

Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist.

K. Ward, B. R. Smith, R. Keenan, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Evidence for cytosolic glutathione transferase-mediated denitrosation of nitrosocimetidine and 1-methyl-2-nitro-1-nitrosoguanidine.

D. Jensen, G. Stelman, 1987, Carcinogenesis.

The discovery of potent and long-acting oral factor Xa inhibitors with tetrahydroisoquinoline and benzazepine P4 motifs.

Stefan Senger, Savvas Kleanthous, Iain M McLay, 2011, Bioorganic & medicinal chemistry letters.

Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.

B. Smith, K. Ward, J. Kehler, 2004, Drug metabolism and disposition: the biological fate of chemicals.

The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers

D. Brocks, J. Upward, M. Dennis, 1996, European Journal of Clinical Pharmacology.

Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase

K. Ward, B. R. Smith, J. Mumaw, 2001, Xenobiotica; the fate of foreign compounds in biological systems.

Comparison of N,N'-diarylsquaramides and N,N'-diarylureas as antagonists of the CXCR2 chemokine receptor.

K. Ward, H. Sarau, J. Foley, 2007, Bioorganic & medicinal chemistry letters.